Xiang Zhang

FAQ About Xiang Zhang

• What is Xiang Zhang's address?

  Xiang Zhang is located at
  Stoke-on-Trent, Stoke-on-Trent, United Kingdom

• What is Xiang Zhang's job title?

  Xiang Zhang is a
  • Royal Society Industry Fellow at University of Cambridge, Head of Medical Materials & Devices (Principal Consultant), Lucideon, with 30 years experience, Dr Xiang Zhang is currently leading combined academic and industrial research program in the following areas: • Hybrid Biocomposites New generation of biomaterials needs understanding the relationship between nanostructure and properties, in particular nanocomposites that contain inorganic and organic constituents, and the extent to which each constituent affects biocompatibility and bioactivity in medical applications. Bone, which consists largely of natural collagen and hydroxyapatite in a nanometre scale , is a good example. Understanding the nano-characteristics and resulting biological responses of ‘smart’ composite biomaterials will be the key to develop safer and more effective synthetic products in the future. • Hydroxyapatite Based Materials To make HA to be adapted by different biological species, we have changed the charge potential (positive or negative) and surface characteristics by multi-substituting different elements, say >= 2, into HA crystals. It is now possible to make a series of HA-based biomaterials with varied (+ or -) charge strength into HA to meet different application needs. • Controlled Release Technology: We are developing new inorganic CRT in combination with organic polymer CRT, which will play important role for new drug development and reformulation of exiting drugs. There are not shortages of drugs in the world but smart drug delivery systems that can deliver drug/s in a controlled manner for applications like drugs that are both too difficult or too easy to be dissolved plus macromolecules like protein/peptide. • Mini-medical Devices – Biosensors: with success of glucose biosensor, new biosensors research is in demanding for diagnostics of cholesterol, triglyceride, HbA1c (glycosylated haemoglobin), uric acid, lactate, H2O2, as well as blood gas. Specialties: • Biosensor design, development and manufacturing plus trouble shooting; • Polymer development and failure analysis for R&D and manufacturing; • Hybrid Biocomposites R&D: design inorganic & organic nano/micro structure for orthopedic applications; • Hydroxyapatite-based Materials: introduce new elements into HA crystals to change charge potential negatively or positively to create a range of HA-based materials for new medical applications. • Controlled Release Technology for healthcare University Of Cambridge

• What industry does Xiang Zhang currently work in?

  Xiang Zhang currently works in the
  University Of Cambridge

• What is Xiang Zhang's area of expertise?

  Xiang Zhang specializes in
  • Royal Society Industry Fellow at University of Cambridge, Head of Medical Materials & Devices (Principal Consultant), Lucideon, with 30 years experience, Dr Xiang Zhang is currently leading combined academic and industrial research program in the following areas: • Hybrid Biocomposites New generation of biomaterials needs understanding the relationship between nanostructure and properties, in particular nanocomposites that contain inorganic and organic constituents, and the extent to which each constituent affects biocompatibility and bioactivity in medical applications. Bone, which consists largely of natural collagen and hydroxyapatite in a nanometre scale , is a good example. Understanding the nano-characteristics and resulting biological responses of ‘smart’ composite biomaterials will be the key to develop safer and more effective synthetic products in the future. • Hydroxyapatite Based Materials To make HA to be adapted by different biological species, we have changed the charge potential (positive or negative) and surface characteristics by multi-substituting different elements, say >= 2, into HA crystals. It is now possible to make a series of HA-based biomaterials with varied (+ or -) charge strength into HA to meet different application needs. • Controlled Release Technology: We are developing new inorganic CRT in combination with organic polymer CRT, which will play important role for new drug development and reformulation of exiting drugs. There are not shortages of drugs in the world but smart drug delivery systems that can deliver drug/s in a controlled manner for applications like drugs that are both too difficult or too easy to be dissolved plus macromolecules like protein/peptide. • Mini-medical Devices – Biosensors: with success of glucose biosensor, new biosensors research is in demanding for diagnostics of cholesterol, triglyceride, HbA1c (glycosylated haemoglobin), uric acid, lactate, H2O2, as well as blood gas. Specialties: • Biosensor design, development and manufacturing plus trouble shooting; • Polymer development and failure analysis for R&D and manufacturing; • Hybrid Biocomposites R&D: design inorganic & organic nano/micro structure for orthopedic applications; • Hydroxyapatite-based Materials: introduce new elements into HA crystals to change charge potential negatively or positively to create a range of HA-based materials for new medical applications. • Controlled Release Technology for healthcare

• Which languages does Xiang Zhang speak? 

  Xiang Zhang speaks the following languages:
  No languages available.

• Which industries has Xiang Zhang previously worked in?   

  Xiang Zhang has prior experience in the following industries:
  Cambridge Nanotech , Abbott

• What is Xiang Zhang’s work experience?  

  Xiang Zhang has the following professional experience:
  University Of Cambridge , Lucideon , Cambridge Nanotech , Abbott .

• How can I find Xiang Zhang on LinkedIn?  

  You can view Xiang Zhang’s
  LinkedIn profile at LinkedIn URL.

• What are Xiang Zhang’s work email addresses?  

  Xiang Zhang’s work email addresses are
  [email protected] .

• What company does Xiang Zhang work for?  

  Xiang Zhang works at
  University Of Cambridge